FindTrial
Sign In

The Effect of Neoadjuvant Chemotherapy on the Postoperative Awakening Quality of Tumor Patients

The Effect of Neoadjuvant Chemotherapy on the Postoperative Awakening Quality of Tumor Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118641
Enrollment
Unknown
Registered
2026-02-09
Start date
2026-02-14
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Awakening Quality

Interventions

Chemotherapy Group:None
Non-chemotherapy Group:None

Sponsors

The Second People's Hospital of Wuhu
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients aged >= 18 years, with American Society of Anesthesiologists (ASA) physical status ?–?, and histologically confirmed malignant tumors.

Exclusion criteria

Exclusion criteria: 1.Refusal to participate in this study; 2.history of liver or kidney diseases, mental system disorders, alcohol consumption, or nervous system lesions; 3. preoperative abnormal liver or kidney function; 4.non-general anesthesia; 5.and planned transfer to the intensive care unit (ICU).

Design outcomes

Primary

MeasureTime frame
Anesthesia recovery time;—

Secondary

MeasureTime frame
Number of cases with delayed awakening;Age;Body Mass Index;ASA physical status classification;Smoking history;Drinking history;Blood loss volume;Intraoperative fluid volume;Urine output;Dosage of anesthetic drugs;Operation time;Anesthesia time;Spontaneous breathing recovery time;Eye opening time;Consciousness recovery time;Extubation time;Postoperative Data;—

Countries

China

Contacts

Public ContactWang Shaolin

The Second People's Hospital of Wuhu

wuhuwsl@163.com+86 180 5531 6261

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026